Surgical Castration in Hormone-Refractory Metastatic Prostate Cancer Patients Can Be an Alternative for Medical Castration

Background. Most patients with metastatic prostate cancer are endocrinologically treated with LHRH agonist, but finally castration-refractory and hormone-refractory cancers occur. Serum testosterone levels get low to “the castration level” by LHRH agonists but may not get low enough against castrati...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Zaitsu, Masayoshi, Yamanoi, Mariko, Mikami, Koji, Takeshima, Yuta, Okamoto, Naohiko, Imao, Sadao, Tonooka, Akiko, Takeuchi, Takumi
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi Publishing Corporation 2012
Assuntos:
Clinical Study
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3130489/
https://ncbi.nlm.nih.gov/pubmed/21754927
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/979154
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares